Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with
sarcoidosis-associated interstitial lung disease and pulmonary hypertension.